Stocks · News reference
Intuitive Surgical shares edge 0.14% higher after hours following disclosure of executive vice president's 231-share insider sale.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Shopify and Intuitive Surgical, despite significant year-to-date declines of 19% and 29% respectively, present attractive buying opportunities. Shopify's strong Q2 results and AI-powered initiatives position it well in e-commerce, while Intuitive Surgical's market leadership in robotic-assisted surgery and high switching costs provide competitive advantages despite increased competition from Medtronic.
Medtronic's stock is down 3% this year despite strong fundamentals, presenting a buying opportunity for growth-oriented investors. The company's Hugo robotic-assisted surgery system is gaining traction and eroding competitor Intuitive Surgical's market dominance. With Q1 FY2027 revenue up 13.7% YoY, raised full-year guidance, a near-Dividend King status (49 consecutive years of dividend increases), and attractive valuation metrics, analysts view the stock as undervalued compared to peers.
Intuitive Surgical (ISRG) gained 2.38% to $377.94 on September 14, 2026, outperforming a declining broader market. The company is expected to report EPS of $2.61 (up 8.75% YoY) and quarterly revenue of $2.88 billion (up 14.98% YoY). However, the stock has declined 6.43% over the past month and carries a Zacks Rank #3 (Hold) rating with a premium valuation at 34.39 Forward P/E versus the industry average of 21.78.
Filed: 2026-08-03 AccNo: 0001628280-26-051561 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits